CNS5:Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
← Older edit
VisualWikitext
m author added
m due date
 
(24 intermediate revisions by 5 users not shown)
Line 44: Line 44:
|6/25/2023
|6/25/2023
|
|
|PENDING
|COMPLETE
|
|
|Laveniya Satgunaseelan (LS)
|Laveniya Satgunaseelan (LS)
Line 52: Line 52:
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|Disease
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|Riley Lochner (trainee);
Shashi Shetty (mentor)
|6/7/2022
|6/7/2022
|
|
Line 63: Line 64:
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|Disease
|Disease
|Meenakshi Mehrotra
|Jieying Wu
|
|11/18/2025
|
|01/15/2026
|PENDING
|PENDING
|
|
Line 110: Line 111:
|5/3/2024
|5/3/2024
|
|
|PENDING
|PENDING - email reminder 9/4/2025
|
|
|LS
|LS
Line 118: Line 119:
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|Disease
|Disease
|Laveniya Satgunaseelan (Linda Cooley - previous version)
|Laveniya Satgunaseelan
|
|
|
|
|PENDING
|COMPLETE
|
|
|LS
|LS
Line 173: Line 174:
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|Disease
|Disease
|Jeremy Pulvers
|Layla Zhu
|9/13/2022<br />
|<br />3/2/2026
|
|
|PENDING
|PENDING
Line 184: Line 185:
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|Disease
|Disease
|Wahab Khan
|2/8/2026
|
|
|
|PENDING
|
|
|
|
|
|
Line 198: Line 199:
|15/04/2025
|15/04/2025
|
|
|PENDING
|COMPLETE
|
|2/8/2026 (Feb 8)
|LS
|LS
|
|
Line 228: Line 229:
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
|Disease
|Disease
|Milana.Djonovic (trainee), Laveniya/Madina
|4/26/2026
|6/15/2026
|PENDING
|
|
|
|LS
|
|
|
|
|
|
|
|
Line 341: Line 342:
|9/11/2024
|9/11/2024
|
|
|Pending
|COMPLETE
|
|8/7/2025
|
|LS
|
|LS
|Testing 9/2024 somatic template
|Used for testing 9/2024 somatic template
|-
|-
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
Line 415: Line 416:
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|Disease
|Disease
|
|Laveniya Satgunaseelan
|
|2/4/2026
|
|30/6/2026
|
|PENDING
|
|
|
|
Line 426: Line 427:
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
|Disease
|Disease
|
|Laveniya Satgunaseelan
|
|2/4/2026
|
|30/6/2026
|
|PENDING
|
|
|
|
Line 437: Line 438:
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|Disease
|Disease
|
|Laveniya Satgunaseelan
|
|2/4/2026
|
|30/6/2026
|
|PENDING
|
|
|
|
Line 611: Line 612:
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|Disease
|Disease
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|Lisa Lansdon, PhD (LGG trainee just finished);
Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|9/20/21
|
|
Line 633: Line 635:
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|Disease
|Disease
|Hannah Wollenzien
|1/11/2026
|
|
|Pending
|
|
|
|MS
|
|
|
|
|
|
|
Line 797: Line 799:
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|Disease
|Disease
|Fang Fang (trainee)+Katie Schieffer (mentor)
|11/19/2025
|6/15/2026
|Pending
|
|
|
|LS
|
|
|
|
|
|
|
|
Line 851: Line 853:
|[[CNS5:Schwannoma|Schwannoma]]
|[[CNS5:Schwannoma|Schwannoma]]
|Disease
|Disease
|
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[CNS5:Neurofibroma|Neurofibroma]]
|[[CNS5:Neurofibroma|Neurofibroma]]
|Disease
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[CNS5:Perineurioma|Perineurioma]]
|
|
|
|
|
|-
|[[CNS5:Perineurioma|Perineurioma]]
|Disease
|Disease
|
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|Disease
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|
|
|
|
|
|-
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
Line 917: Line 919:
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|Disease
|
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
Line 992: Line 994:
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Disease
|
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
Line 1,057: Line 1,059:
|-
|-
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|Disease
|Disease
|
|
Line 1,064: Line 1,077:
|
|
|
|
|
|
|
|-
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,078: Line 1,113:
|
|
|-
|-
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|[[CNS5:Chordoma|Chordoma]]
|Disease
|Disease
|
|
Line 1,089: Line 1,124:
|
|
|-
|-
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|
|
====CHAPTER 9 (MELANOCYTIC TUMOURS)====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|Disease
|Disease
|
|
Line 1,111: Line 1,156:
|
|
|-
|-
|[[CNS5:Chordoma|Chordoma]]
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
|Disease
|Disease
|
|
Line 1,123: Line 1,168:
|-
|-
|
|
====CHAPTER 9 (MELANOCYTIC TUMOURS)====
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)====
|
|
----
----
Line 1,143: Line 1,188:
----
----
|-
|-
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|Disease
|Disease
|
|
Line 1,154: Line 1,199:
|
|
|-
|-
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
!'''Disease'''
|Disease
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''
|
!'''Associate Editor'''
|
!'''Date of Last Editor Review'''
|
!'''Notes'''
|-
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|Disease
|
|
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|Disease
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|
|Disease
|
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
!'''Disease'''
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
!'''Page Type'''
|Disease
!'''<span style="color:#0070C0">Author'''
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
!'''Date Assigned to Author'''
|N/A
!'''Target Completion Date'''
|N/A
!'''Author Content (Pending or Complete)'''
|N/A
!'''Date Completed by Author'''
|N/A
!'''Associate Editor'''
|N/A
!'''Date of Last Editor Review'''
|N/A
!'''Notes'''
|
|-
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
|Disease
|Disease
|
|
Line 1,219: Line 1,265:
|
|
|-
|-
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|Disease
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|
|MS
|
|
|
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
|
|-
|
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
|
|Disease
|
|
|-
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|Disease
|
|
|
|
Line 1,241: Line 1,287:
|
|
|-
|-
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|Disease
|Disease
|
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|Disease
|
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|Disease
|Jennie Thurston
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|7/2/2023
|N/A
|
|N/A
|PENDING
|N/A
|
|N/A
|MS
|N/A
|N/A
|
|
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
|-
|-
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|
|
====CHAPTER 11 (GERM CELL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|Disease
|
|
|
|
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
|Disease
|Disease
|
|
Line 1,307: Line 1,385:
|
|
|-
|-
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|
|
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|-
|-
!'''Disease'''
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|Disease
|
|
Line 1,340: Line 1,417:
|
|
|-
|-
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|Disease
|Disease
|
|
Line 1,351: Line 1,428:
|
|
|-
|-
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|
|
====CHAPTER 11 (GERM CELL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|Disease
|
|
|
|
|
|
|
|
----
|
|
----
|-
|-
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|Disease
|Disease
|
|
Line 1,382: Line 1,460:
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|
|
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION====
====CHAPTER 13 (METASTASES TO THE CNS)====
|
|
----
----
Line 1,404: Line 1,493:
----
----
|-
|-
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|Disease
|Disease
|
|
Line 1,415: Line 1,504:
|
|
|-
|-
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
|Disease
|Disease
|
|
Line 1,426: Line 1,515:
|
|
|-
|-
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|
|
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|Disease
|
|
|
|
|
|
|
|
----
|
|
----
|-
|-
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
!'''Disease'''
|[[CNS5:Schwannomatosis|Schwannomatosis]]
!'''Page Type'''
|Disease
!'''<span style="color:#0070C0">Author'''
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
!'''Date Assigned to Author'''
|N/A
!'''Target Completion Date'''
|N/A
!'''Author Content (Pending or Complete)'''
|N/A
!'''Date Completed by Author'''
|N/A
!'''Associate Editor'''
|N/A
!'''Date of Last Editor Review'''
|N/A
!'''Notes'''
|
|-
|-
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
====CHAPTER 13 (METASTASES TO THE CNS)====
|-
|
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
----
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
----
|N/A
|
|N/A
----
|N/A
|
|N/A
----
|N/A
|
|N/A
----
|
----
|
----
|
|
----
|
----
|-
|-
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|
|
|
|
|
|
|-
|-
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 1,543: Line 1,655:
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|-
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 1,554: Line 1,666:
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|-
|[[CNS5:Schwannomatosis|Schwannomatosis]]
|[[CNS5:Carney_complex|Carney complex]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 1,576: Line 1,677:
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|-
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 1,598: Line 1,688:
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|-
!'''Disease'''
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|Disease
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
Line 1,621: Line 1,699:
|N/A
|N/A
|N/A
|N/A
|
|-
|-
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 1,631: Line 1,710:
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|-
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
|Disease
|Disease
|
|
Line 1,651: Line 1,719:
|
|
|
|
|
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[CNS5:Carney_complex|Carney complex]]
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 1,686: Line 1,754:
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|-
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 1,752: Line 1,765:
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|-
|}
|}

Latest revision as of 11:05, 28 April 2026

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
Astrocytoma, IDH-mutant Disease Meenakshi Mehrotra 6/25/2023 COMPLETE Laveniya Satgunaseelan (LS) 2021 template added
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease Riley Lochner (trainee);

Shashi Shetty (mentor)

6/7/2022 COMPLETE LS 2021 template added
Glioblastoma, IDH-wildtype Disease Jieying Wu 11/18/2025 01/15/2026 PENDING LS Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
Diffuse astrocytoma, MYB- or MYBL1-altered Disease Scott Smith 6/27/2023 COMPLETE LS 2021 template added (page created 6/27/23)
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease Scott Smith 5/3/2024 PENDING - email reminder 9/4/2025 LS
Diffuse midline glioma, H3 K27-altered Disease Laveniya Satgunaseelan COMPLETE LS 2021 template added
Diffuse hemispheric glioma, H3 G34-mutant Disease Xiaolin (Lynn) Hu 2/21/2022 COMPLETE LS 2021 template added
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease Madina Sukhanova 10/28/2022 COMPLETE LS 2021 template added
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease Layla Zhu
3/2/2026 		PENDING LS 2021 template added
High-grade astrocytoma with piloid features Disease Wahab Khan 2/8/2026 PENDING
Pleomorphic xanthoastrocytoma Disease Wahab Khan 15/04/2025 COMPLETE 2/8/2026 (Feb 8) LS 2021 template added
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease Milana.Djonovic (trainee), Laveniya/Madina 4/26/2026 6/15/2026 PENDING LS
Ganglioglioma Disease Leila Moayed-Aloei 6/30/2022 COMPLETE LS 2021 template added
Gangliocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease Laveniya Satgunaseelan 9/11/2024 COMPLETE 8/7/2025 LS LS Used for testing 9/2024 somatic template
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease Laveniya Satgunaseelan 2/4/2026 30/6/2026 PENDING
Supratentorial ependymoma, ZFTA fusion-positive Disease Laveniya Satgunaseelan 2/4/2026 30/6/2026 PENDING
Supratentorial ependymoma, YAP1 fusion-positive Disease Laveniya Satgunaseelan 2/4/2026 30/6/2026 PENDING
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myxopapillary ependymoma Disease
Subependymoma Disease

CHAPTER 3 (CHOROID PLEXUS TUMOURS)
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease

CHAPTER 4 (EMBRYONAL TUMOURS)
Medulloblastoma, WNT-activated Disease Lisa Lansdon, PhD (LGG trainee just finished);

Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City

9/20/21 COMPLETE Holli Drendel (interim)/Laveniya Satgunaseelan (LS) 9/22/2022 2021 template added
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease Hannah Wollenzien 1/11/2026 Pending MS
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease

CHAPTER 5 (PINEAL TUMOURS)
Pineocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease Fang Fang (trainee)+Katie Schieffer (mentor) 11/19/2025 6/15/2026 Pending LS
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease

CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
Schwannoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Neurofibroma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Perineurioma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Hybrid nerve sheath tumours Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Malignant melanotic nerve sheath tumour Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Malignant peripheral nerve sheath tumour Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease

CHAPTER 7 (MENINGIOMA)
Meningioma Disease

CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
Solitary fibrous tumour Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CIC-rearranged sarcoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Mesenchymal chondrosarcoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Chondrosarcoma Disease
Chordoma Disease

CHAPTER 9 (MELANOCYTIC TUMOURS)
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease

CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
Primary diffuse large B-cell lymphoma of the CNS Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Intravascular large B-cell lymphoma Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
MALT lymphoma of the dura Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease Jennie Thurston 7/2/2023 PENDING MS 2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)" and "ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)"?
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Rosai-Dorfman disease Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Juvenile xanthogranuloma Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Langerhans cell histiocytosis Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Histiocytic sarcoma Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A

CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours of the CNS Disease

CHAPTER 12 (TUMOURS OF THE SELLAR REGION
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 13 (METASTASES TO THE CNS)
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease

CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Schwannomatosis Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Tuberous sclerosis Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cowden syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Constitutional mismatch repair deficiency syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Familial adenomatous polyposis 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Naevoid basal cell carcinoma syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Rhabdoid tumour predisposition syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Carney complex Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Familial paraganglioma syndromes Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Melanoma-astrocytoma syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Familial retinoblastoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
BAP1 tumour predisposition syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Fanconi anaemia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
ELP1-medulloblastoma syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Retrieved from "https://content.ccga.io/index.php?title=CNS5:Volunteer_Assignments_and_Opportunities&oldid=21175"